Renovaro Inc. (RENB) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Renovaro Inc. (RENB:NASDAQ), powered by AI.

Current Price
$2.45
P/E Ratio
-0.2
Market Cap
40M
Sector
Healthcare
What is the Renovaro Inc. stock price forecast?

Renovaro Inc. is currently trading at $2.45. View real-time AI analysis on Alpha Lenz.

What is Renovaro Inc. insider trading activity?

View the latest insider trading data for Renovaro Inc. on Alpha Lenz.

What is Renovaro Inc.'s P/E ratio?

Renovaro Inc.'s P/E ratio is -0.2.

Renovaro Inc.

NASDAQ · RENB
$2.45-0.47(-16.10%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Renovaro Inc.'s future dividend policy...
Alpha Chat Insight

Renovaro Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -321.8%.

Ask for details

Company Overview

Renovaro Inc. is a dynamic company engaged in the renewable energy sector, focusing on sustainable and environmentally friendly power solutions. The primary function of Renovaro Inc. is to design, develop, and implement renewable energy systems, such as solar panels, wind turbines, and energy storage solutions. By offering cutting-edge technologies and innovative approaches, the company plays a crucial role in the transition towards sustainable energy sources, impacting key industries like utilities, construction, and transportation. Renovaro Inc.'s contributions are vital in supporting global efforts to reduce carbon emissions and achieve climate goals. The company's commitment to environmentally responsible practices positions it as a significant player in the market, driving growth in green technology and infrastructure development. Through partnerships with governments, private enterprises, and non-profits, Renovaro Inc. helps expand access to renewable energy, promoting a cleaner and more sustainable energy future. As the demand for clean energy surges worldwide, Renovaro Inc.'s role in shaping sustainable energy landscapes becomes increasingly critical, ensuring the alignment of economic growth with environmental stewardship.

CEOMr. David H. Weinstein
SectorHealthcare
IndustryBiotechnology
Employees25

Company Statistics

FY 2025

Profile

$40.44MMarket Cap
$0.00Revenue
0.00Shares Out
25Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.23P/E
-1.89P/B
N/AEV/Sales
-2.76EV/EBITDA
-5.14P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-207.76%ROA
-321.81%ROE
-206.91%ROIC

Financial Health

$92.70KCash & Cash Equivalents
$29.49MNet Debt
-138.55%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Renovaro Inc. (ticker: RENB) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 25 employees. Market cap is $40M.

The current price is $2.45 with a P/E ratio of -0.23x and P/B of -1.89x.

ROE is -321.81%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Renovaro Inc. (RENB) Stock Forecast 2026 $2.45 — Price, Financials & Analyst Targets | Alpha Lenz